Royal Bank Of Canada Sqz Biotechnologies CO Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.27 - $0.68 $174 - $439	646 New	646 $0
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $3,872 - $6,990	-1,398 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.01 - $10.42 $13,317 - $34,604	-3,321 Reduced 70.38%	1,398 $7,000
Q4 2021 Feb 14, 2022	BUY	$8.93 - $14.85 $14,823 - $24,651	1,660 Added 54.27%	4,719 $42,000
Q3 2021 Nov 15, 2021	BUY	$11.46 - $15.77 $17,190 - $23,655	1,500 Added 96.22%	3,059 $44,000
Q2 2021 Aug 16, 2021	BUY	$11.32 - $14.45 $17,647 - $22,527	1,559 New	1,559 $23,000

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.